PellePharm closes $20mm Series B round
PellePharm Inc. (oncology) raised $20mm through a three-tranche Series B round that was led by BridgeBio Pharma.
- Topical Delivery
- Drug Delivery
- Venture Financing
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.